학술논문

Impact of systematic EGFR and KRAS mutation evaluation on progression-free survival and overall survival in patients with advanced non-small-cell lung cancer treated by erlotinib in a French prospective cohort (ERMETIC project-Part 2)
Document Type
Article
Source
In: Journal of Thoracic Oncology. (Journal of Thoracic Oncology, October 2012, 7(10):1490-1502)
Subject
Language
English
ISSN
15561380
15560864